ArticleJNCI cancer spectrum2018

Strategy for Assessing New Drug Value in Orphan Diseases: An International Case Match Control Analysis of the PROPEL Study.

Owen A O'Connor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.